Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 27, 2020
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
[ Tue, Oct 27th 2020
] - WOPRAI
Kevin Mcveigh Maintained (TBI) at Hold with Increased Target to $16 on, Oct 27th, 2020
Kevin Mcveigh of Credit Suisse, Maintained "TrueBlue, Inc." (TBI) at Hold with Increased Target from $13 to $16 on, Oct 27th, 2020.
Kevin has made no other calls on TBI in the last 4 months.
There are 2 other peers that have a rating on TBI. Out of the 2 peers that are also analyzing TBI, 1 agrees with Kevin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Josh Vogel of "Sidoti & Co." Maintained at Hold with Increased Target to $16 on, Thursday, October 1st, 2020
This is the rating of the analyst that currently disagrees with Kevin
- John Healy of "Northcoast Research" Upgraded from Hold to Strong Buy on, Tuesday, July 21st, 2020
